Formyl-HIST1H3A (K23) Antibody

Shipped with Ice Packs
In Stock

Description

Target and Biological Context

HIST1H3A (UniProt ID: P68431) encodes histone H3.1, a core component of nucleosomes. Lysine 23 (K23) undergoes formylation, a PTM linked to chromatin remodeling and transcriptional regulation . This modification is part of a broader landscape of histone modifications, including acetylation, methylation, and phosphorylation, which collectively fine-tune DNA accessibility .

Key Findings

  • Chromatin Dynamics: Detects formyl-K23 modifications in HeLa cells treated with 30 mM sodium butyrate, a histone deacetylase inhibitor .

  • Subcellular Localization: Nuclear-specific staining in immunofluorescence assays (e.g., HepG2 and HeLa cells) .

  • Western Blot Validation: Bands at ~18 kDa (consistent with histone H3.1) in HeLa whole-cell lysates .

Comparative Analysis with Other HIST1H3A Modifications

Formyl-K23 is one of several PTMs on HIST1H3A. Below is a comparison of antibodies targeting adjacent residues:

Modification SiteAntibody TypeApplicationsKey References
K23 (Formyl)Polyclonal (Rabbit)WB, IF, ELISA
K23 (2-Hydroxyisobutyryl)Polyclonal (Rabbit)WB, IF, ChIP
K27 (Acetyl)Polyclonal (Rabbit)WB, IF, ChIP
S28 (Phospho)Polyclonal (Rabbit)ELISA, IF

Technical Validation Data

  • Immunofluorescence: Nuclear staining in formaldehyde-fixed cells, validated with FITC-conjugated secondary antibodies .

  • Western Blot: Specificity confirmed using sodium butyrate-treated lysates, with absence of cross-reactivity to unmodified H3 .

  • Species Cross-Reactivity: Exclusive to human samples; no reactivity observed in mouse or rat .

Limitations and Considerations

  • Specificity: No cross-reactivity with acetylated or methylated H3 variants .

  • Storage Stability: Repeated freeze-thaw cycles degrade performance; aliquot recommended .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
We typically dispatch orders within 1-3 business days of receipt. Delivery times may vary depending on the method of purchase and location. Please consult your local distributor for specific delivery time information.
Synonyms
H3 histone family member E pseudogene antibody; H3 histone family; member A antibody; H3/A antibody; H31_HUMAN antibody; H3F3 antibody; H3FA antibody; Hist1h3a antibody; HIST1H3B antibody; HIST1H3C antibody; HIST1H3D antibody; HIST1H3E antibody; HIST1H3F antibody; HIST1H3G antibody; HIST1H3H antibody; HIST1H3I antibody; HIST1H3J antibody; HIST3H3 antibody; histone 1; H3a antibody; Histone cluster 1; H3a antibody; Histone H3 3 pseudogene antibody; Histone H3.1 antibody; Histone H3/a antibody; Histone H3/b antibody; Histone H3/c antibody; Histone H3/d antibody; Histone H3/f antibody; Histone H3/h antibody; Histone H3/i antibody; Histone H3/j antibody; Histone H3/k antibody; Histone H3/l antibody
Target Names
Uniprot No.

Target Background

Function
Histone H3 is a core component of the nucleosome. Nucleosomes function in wrapping and compacting DNA into chromatin, limiting DNA accessibility to cellular machinery that requires DNA as a template. Histones thus play a central role in transcription regulation, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated by a complex set of post-translational modifications of histones, also known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Research indicates that epigenetic regulation in cancer may occur by inducing E3 ubiquitin ligase NEDD4-dependent histone H3 ubiquitination. PMID: 28300060
  2. The identification of increased expression of H3K27me3 during a patient's clinical course can be helpful in determining whether tumors are heterochronous. PMID: 29482987
  3. Studies have shown that JMJD5, a Jumonji C (JmjC) domain-containing protein, is a Cathepsin L-type protease that mediates histone H3 N-tail proteolytic cleavage under stress conditions that cause a DNA damage response. PMID: 28982940
  4. Evidence suggests that the Ki-67 antigen proliferative index has important limitations and that phosphohistone H3 (PHH3) is an alternative proliferative marker. PMID: 29040195
  5. Research findings indicate that cytokine-induced histone 3 lysine 27 trimethylation is a mechanism that stabilizes gene silencing in macrophages. PMID: 27653678
  6. This data suggests that, in the early developing human brain, HIST1H3B constitutes the largest proportion of H3.1 transcripts among H3.1 isoforms. PMID: 27251074
  7. In a series of 47 diffuse midline gliomas, histone H3-K27M mutation was mutually exclusive with IDH1-R132H mutation and EGFR amplification, rarely co-occurred with BRAF-V600E mutation, and was commonly associated with p53 overexpression, ATRX loss, and monosomy 10. Among these K27M+ diffuse midline gliomas. PMID: 26517431
  8. Data show that histone chaperone HIRA co-localizes with viral genomes, binds to incoming viral and deposits histone H3.3 onto these. PMID: 28981850
  9. Experiments have shown that PHF13 binds specifically to DNA and to two types of histone H3 methyl tags (lysine 4-tri-methyl or lysine 4-di-methyl) where it functions as a transcriptional co-regulator. PMID: 27223324
  10. Hemi-methylated CpGs DNA recognition activates UHRF1 ubiquitylation towards multiple lysines on the H3 tail adjacent to the UHRF1 histone-binding site. PMID: 27595565
  11. This is the first report describing the MR imaging features of pediatric diffuse midline gliomas with histone H3 K27M mutation. PMID: 28183840
  12. Approximately 30% of pediatric high-grade gliomas (pedHGG), including GBM and DIPG, harbor a lysine 27 mutation (K27M) in histone 3.3 (H3.3), which is correlated with poor outcome and has been shown to influence EZH2 function. PMID: 27135271
  13. H3F3A K27M mutation in adult cerebellar HGG is not uncommon. PMID: 28547652
  14. Data show that lysyl oxidase-like 2 (LOXL2) is a histone modifier enzyme that removes trimethylated lysine 4 (K4) in histone H3 (H3K4me3) through an amino-oxidase reaction. PMID: 27735137
  15. Histone H3 lysine 9 (H3K9) acetylation was most prevalent when the Dbf4 transcription level was highest, whereas the H3K9me3 level was greatest during and just after replication. PMID: 27341472
  16. The SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing. PMID: 27614073
  17. Research suggests that binding of the helical tail of histone 3 (H3) with PHD ('plant homeodomain') fingers of BAZ2A or BAZ2B (bromodomain adjacent to zinc finger domain 2A or 2B) requires molecular recognition of secondary structure motifs within the H3 tail and could represent an additional layer of regulation in epigenetic processes. PMID: 28341809
  18. Results demonstrate a novel mechanism by which Kdm4d regulates DNA replication by reducing the H3K9me3 level to facilitate the formation of the preinitiation complex. PMID: 27679476
  19. Histone H3 modifications caused by traffic-derived airborne particulate matter exposures in leukocytes. PMID: 27918982
  20. A key role of persistent histone H3 serine 10 or serine 28 phosphorylation in chemical carcinogenesis through regulating gene transcription of DNA damage response genes. PMID: 27996159
  21. hTERT promoter mutations are frequent in medulloblastoma and are associated with older patients, prone to recurrence and located in the right cerebellar hemisphere. On the other hand, histone 3 mutations do not seem to be present in medulloblastoma. PMID: 27694758
  22. AS1eRNA-driven DNA looping and activating histone modifications promote the expression of DHRS4-AS1 to economically control the DHRS4 gene cluster. PMID: 26864944
  23. Data suggest that nuclear antigen Sp100C is a multifaceted histone H3 methylation and phosphorylation sensor. PMID: 27129259
  24. The authors propose that histone H3 threonine 118 phosphorylation via Aurora-A alters the chromatin structure during specific phases of mitosis to promote timely condensin I and cohesin disassociation, which is essential for effective chromosome segregation. PMID: 26878753
  25. Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its H3 histone recognition. PMID: 27045799
  26. Functional importance of H3K9me3 in hypoxia, apoptosis, and repression of APAK. PMID: 25961932
  27. Taken together, the authors verified that histone H3 is a real substrate for GzmA in vivo in the Raji cells treated by staurosporin. PMID: 26032366
  28. Circulating H3 levels correlate with mortality in sepsis patients and inversely correlate with antithrombin levels and platelet counts. PMID: 26232351
  29. Double mutations on the residues in the interface (L325A/D328A) decrease the histone H3 H3K4me2/3 demethylation activity of lysine (K)-specific demethylase 5B (KDM5B). PMID: 24952722
  30. Minichromosome maintenance protein 2 (MCM2) binding is not required for incorporation of histone H3.1-H4 into chromatin but is important for the stability of H3.1-H4. PMID: 26167883
  31. Histone H3 lysine methylation (H3K4me3) plays a crucial mechanistic role in leukemia stem cell (LSC) maintenance. PMID: 26190263
  32. PIP5K1A modulates ribosomal RNA gene silencing through its interaction with histone H3 lysine 9 trimethylation and heterochromatin protein HP1-alpha. PMID: 26157143
  33. Lower-resolution mass spectrometry instruments can be utilized for histone post-translational modifications (PTMs) analysis. PMID: 25325711
  34. Inhibition of lysine-specific demethylase 1 activity prevented IL-1beta-induced histone H3 lysine 9 (H3K9) demethylation at the microsomal prostaglandin E synthase 1 (mPGES-1) promoter. PMID: 24886859
  35. De novo CENP-A assembly and kinetochore formation on human centromeric alphoid DNA arrays are regulated by a histone H3K9 acetyl/methyl balance. PMID: 22473132

Show More

Hide All

Database Links

HGNC: 4766

OMIM: 137800

KEGG: hsa:8350

STRING: 9606.ENSP00000444823

UniGene: Hs.132854

Involvement In Disease
Glioma (GLM)
Protein Families
Histone H3 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is the significance of Histone H3 K23 acetylation in chromatin regulation?

Histone H3 acetylation at lysine 23 (K23) represents an important epigenetic modification that affects chromatin structure and accessibility. Acetylation of histone tails generally neutralizes the positive charge of lysine residues, weakening their interaction with negatively charged DNA, which subsequently leads to a more open chromatin structure . H3K23 acetylation specifically contributes to transcriptional regulation, DNA repair processes, and chromosome stability by modifying the nucleosome, which wraps and compacts DNA into chromatin . This modification works in concert with other histone marks as part of the "histone code" that determines the functional state of chromatin regions . In research contexts, detecting H3K23ac provides valuable insights into gene expression patterns, cell differentiation, and disease mechanisms where epigenetic dysregulation plays a role.

What are the optimal experimental conditions for using H3K23ac antibodies in Western blot applications?

For optimal Western blot results when using H3K23ac antibodies, researchers should consider the following methodological approach:

  • Sample preparation: Extract histones using acid extraction methods for enrichment of histone proteins. For cell culture samples, treatment with histone deacetylase (HDAC) inhibitors like sodium butyrate can increase acetylation levels, enhancing detection sensitivity .

  • Antibody dilution: Use recommended dilution ranges - typically 1:500 to 1:1000 for polyclonal antibodies , or approximately 1 μg/mL for monoclonal antibodies like RM169 .

  • Buffer composition: Store antibodies in appropriate buffer conditions (e.g., 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide) at -20°C for stability .

  • Controls: Include positive controls (e.g., sodium butyrate-treated HeLa cells) and negative controls (untreated samples) to validate antibody specificity .

  • Detection system: Use an appropriate secondary antibody and detection system compatible with the primary antibody species (typically rabbit for these antibodies) .

  • Validation: Confirm specificity by testing against recombinant histone H3.3 preparations with known modification status .

This methodological approach ensures reliable and reproducible detection of H3K23 acetylation in Western blot experiments while minimizing background and non-specific binding.

How can researchers optimize immunofluorescence protocols when using H3K23ac antibodies?

Optimizing immunofluorescence protocols for H3K23ac antibodies requires careful attention to several key parameters:

  • Cell fixation: Use 4% paraformaldehyde for 10-15 minutes at room temperature to preserve epitope accessibility while maintaining cellular structure.

  • Permeabilization: Apply 0.1-0.2% Triton X-100 in PBS for 5-10 minutes to allow antibody access to nuclear targets while preserving histone-DNA interactions.

  • Blocking: Block with 3-5% BSA or normal serum from the secondary antibody host species for 30-60 minutes to reduce non-specific binding.

  • Antibody incubation: For conjugated antibodies like Alexa Fluor® 488 Anti-Histone H3 (acetyl K23) , direct detection can simplify the protocol. For unconjugated antibodies, primary antibody incubation should be performed at optimal dilutions determined empirically, typically overnight at 4°C .

  • Counterstaining: Include nuclear counterstains (DAPI) and cytoskeletal markers (like phalloidin for actin) to provide cellular context for the H3K23ac signal .

  • Controls: Include positive controls (sodium butyrate-treated cells) and negative controls (primary antibody omission and IgG isotype controls) to validate staining specificity .

  • Visualization parameters: Optimize microscope settings, including exposure time, gain, and z-stack acquisition, to capture the nuclear distribution pattern of H3K23ac while avoiding signal saturation.

This careful optimization produces immunofluorescence results that accurately reflect the distribution and intensity of H3K23 acetylation in different cell types and experimental conditions.

How can ChIP-seq experiments with H3K23ac antibodies be designed to investigate its role in transcriptional regulation?

Designing effective ChIP-seq experiments with H3K23ac antibodies requires careful planning and execution:

  • Experimental design: Include biological replicates (minimum n=3) and appropriate controls (input DNA, IgG control, and positive control with known H3K23ac-enriched regions).

  • Chromatin preparation:

    • Cross-link cells with 1% formaldehyde for 10 minutes at room temperature

    • Quench with 125 mM glycine

    • Lyse cells and sonicate chromatin to 200-500 bp fragments

    • Verify fragmentation efficiency by gel electrophoresis

  • Immunoprecipitation optimization:

    • Use ChIP-validated antibodies when available

    • Titrate antibody amounts (2-5 μg per ChIP reaction) against chromatin amount

    • Include spike-in controls for normalization across samples

    • Perform immunoprecipitation overnight at 4°C with rotation

  • Sequencing considerations:

    • Generate paired-end reads (minimum 50 bp) for more accurate mapping

    • Sequence to a depth of 20-30 million uniquely mapped reads

    • Include spike-in controls for normalization

  • Bioinformatic analysis:

    • Map reads to reference genome using appropriate aligners (Bowtie2, BWA)

    • Call peaks with MACS2 or similar peak callers optimized for histone marks

    • Perform differential binding analysis between conditions

    • Correlate H3K23ac peaks with gene expression data and other histone marks

    • Conduct motif enrichment analysis to identify associated transcription factors

  • Validation strategies:

    • Verify selected peaks by ChIP-qPCR

    • Correlate with RNA-seq data to establish functional relationships

    • Consider complementary approaches like CUT&RUN for orthogonal validation

This comprehensive approach enables researchers to generate high-quality ChIP-seq data that accurately reflects the genomic distribution of H3K23ac and its relationship to transcriptional regulation.

What experimental approaches can differentiate between the functional impacts of H3K23 acetylation versus other lysine modifications on the same histone?

Differentiating the functional impacts of H3K23 acetylation from other histone modifications requires sophisticated experimental strategies:

  • Site-specific mutational analysis:

    • Generate lysine-to-arginine (K→R) or lysine-to-glutamine (K→Q) mutations at specific sites

    • K→R prevents acetylation while maintaining positive charge

    • K→Q mimics constitutive acetylation

    • Compare phenotypic effects of K23 mutations versus mutations at other lysine residues

  • CRISPR-based epigenome editing:

    • Target dCas9-HAT (histone acetyltransferase) fusions to specific genomic loci

    • Use different HAT domains with known specificity for K23 versus other lysines

    • Monitor gene expression, chromatin accessibility, and cellular phenotypes

  • Mass spectrometry approaches:

    • Employ quantitative MS/MS to measure co-occurrence of multiple modifications

    • Use middle-down or top-down proteomics to preserve combinatorial modifications

    • Develop statistical models to identify modification patterns associated with specific functions

  • Sequential ChIP (re-ChIP):

    • Perform first immunoprecipitation with H3K23ac antibody

    • Elute and perform second immunoprecipitation with antibodies against other modifications

    • Identify genomic regions with co-occurring modifications

  • Biochemical reconstitution:

    • Use recombinant or synthetic histones with defined modifications

    • Assemble modified nucleosomes in vitro

    • Test binding of nuclear factors, chromatin remodelers, or transcription factors

    • Measure functional outcomes in cell-free transcription systems

  • Reader protein identification:

    • Perform proteomics with modified histone peptides as bait

    • Use BioID or APEX2 proximity labeling with reader domains specific for H3K23ac

    • Compare interactomes of different modified histones

These approaches collectively provide mechanistic insights into the unique functional contributions of H3K23 acetylation compared to other histone modifications.

What are the most common sources of non-specific binding when using H3K23ac antibodies, and how can they be mitigated?

Common sources of non-specific binding and their mitigation strategies include:

  • Cross-reactivity with other acetylated lysines:

    • Use highly specific monoclonal antibodies like RM169 that have been extensively validated against multiple acetylated lysines

    • Verify antibody specificity using peptide competition assays

    • Include appropriate controls (unmodified H3, other acetylated lysines) in validation experiments

  • High background in immunofluorescence:

    • Increase blocking time and concentration (5% BSA or normal serum)

    • Optimize antibody concentration through titration experiments

    • Include additional washing steps with 0.1% Tween-20

    • Use more specific secondary antibodies or directly conjugated primary antibodies

  • Non-specific bands in Western blots:

    • Extract histones using acid extraction to enrich for histone proteins

    • Optimize antibody dilution (typically 1:500-1:1000)

    • Include proper molecular weight markers to identify the ~17 kDa H3 band

    • Use gradient gels (15-20%) for better resolution of histone proteins

  • Batch-to-batch variability:

    • Request lot-specific validation data from manufacturers

    • Perform in-house validation with known positive controls

    • Consider using recombinant monoclonal antibodies for better consistency

  • Species cross-reactivity issues:

    • Verify species reactivity before experiments (most H3K23ac antibodies work across vertebrates due to high conservation)

    • Include species-appropriate positive controls

    • Check if the antibody has been validated in your specific model organism

Implementing these strategies significantly improves signal-to-noise ratio and ensures the specificity of H3K23ac detection across different experimental applications.

How can researchers distinguish between true H3K23 acetylation signals and artifacts in ChIP-seq experiments?

Distinguishing true H3K23ac signals from artifacts in ChIP-seq requires rigorous quality control and validation:

  • Experimental controls:

    • Include input DNA control (non-immunoprecipitated chromatin)

    • Perform IgG control immunoprecipitations

    • Include spike-in controls for normalization

    • Use cell types with known H3K23ac patterns as positive controls

  • Quality metrics assessment:

    • Calculate enrichment relative to input

    • Evaluate strand cross-correlation to measure IP efficiency

    • Check fragment length distribution for consistency

    • Analyze peak width distribution (histone marks typically produce broader peaks than transcription factors)

  • Bioinformatic filtering:

    • Remove blacklisted regions (repetitive elements, centromeres)

    • Apply stringent peak calling parameters (q-value < 0.01)

    • Filter out peaks with unusual shapes or signal-to-noise ratios

    • Perform IDR (Irreproducible Discovery Rate) analysis between replicates

  • Validation approaches:

    • Confirm selected peaks by ChIP-qPCR

    • Compare with publicly available H3K23ac datasets

    • Correlate with other active chromatin marks (H3K27ac, H3K4me3)

    • Validate biological relevance by correlating with gene expression data

  • Technical artifact identification:

    • Look for abnormal enrichment in specific genomic contexts (TSS, enhancers)

    • Check for biases in GC content or mappability

    • Identify and exclude amplification artifacts

    • Be wary of extremely sharp peaks atypical for histone modifications

  • Cross-platform validation:

    • Compare with CUT&RUN or CUT&Tag results

    • Validate with orthogonal techniques like ATAC-seq for open chromatin regions

Implementing these strategies ensures that ChIP-seq data accurately represents the genomic distribution of H3K23 acetylation and minimizes the interpretation of artifacts as biological signals.

How can H3K23ac antibodies be integrated into multi-omics approaches to understand epigenetic regulation during cellular differentiation?

Integrating H3K23ac antibodies into multi-omics approaches requires careful experimental design and data integration:

  • Sequential experimental design:

    • Perform ChIP-seq with H3K23ac antibodies at multiple timepoints during differentiation

    • Conduct RNA-seq on matched samples to correlate histone modifications with gene expression

    • Include ATAC-seq to assess chromatin accessibility changes

    • Consider single-cell approaches for heterogeneous populations

  • Sample preparation coordination:

    • Use biological replicates for all assays

    • Process samples from the same cellular population when possible

    • Implement consistent cell isolation and fixation protocols

    • Include appropriate controls for each assay

  • Integrative analysis approaches:

    • Perform correlation analysis between H3K23ac peaks and gene expression

    • Identify regions with dynamic changes in H3K23ac during differentiation

    • Overlay with chromatin accessibility data to assess functional relevance

    • Conduct transcription factor motif analysis in regions with changing H3K23ac

  • Advanced computational integration:

    • Use machine learning approaches to identify predictive patterns

    • Implement trajectory inference algorithms to map epigenetic changes over time

    • Develop regulatory network models incorporating H3K23ac data

    • Apply dimensionality reduction techniques to visualize multi-omic relationships

  • Functional validation:

    • Target specific regions with dynamic H3K23ac for CRISPR perturbation

    • Manipulate writers or erasers of H3K23ac in differentiation models

    • Perform reporter assays for regions with interesting H3K23ac patterns

    • Use proteomics to identify H3K23ac readers relevant to differentiation

This integrated approach provides a comprehensive understanding of how H3K23 acetylation contributes to the epigenetic regulation of cellular differentiation in concert with other molecular mechanisms.

What are the methodological considerations when investigating the relationship between H3K23 acetylation and DNA damage response pathways?

Investigating the relationship between H3K23 acetylation and DNA damage response (DDR) pathways requires specialized experimental design considerations:

  • DNA damage induction protocols:

    • Use genotoxic agents with different mechanisms (UV, ionizing radiation, hydroxyurea, etc.)

    • Establish dose-response relationships and time courses

    • Include appropriate controls for each damage type

    • Consider site-specific damage induction systems (e.g., laser microirradiation)

  • ChIP-seq adaptations for damage sites:

    • Optimize crosslinking conditions for transient DDR protein-chromatin interactions

    • Consider dual crosslinking approaches (formaldehyde plus ethylene glycol bis-succinimidyl succinate)

    • Use sonication parameters that efficiently recover damaged DNA

    • Implement spike-in controls for normalization across damage conditions

  • Co-localization analysis:

    • Perform sequential ChIP (re-ChIP) for H3K23ac and DDR proteins

    • Use immunofluorescence with H3K23ac antibodies and DDR markers (γH2AX, 53BP1)

    • Quantify spatial relationships using advanced image analysis

    • Consider proximity ligation assays (PLA) to detect close associations

  • Temporal dynamics investigation:

    • Establish precise timelines of H3K23ac changes after damage

    • Compare with kinetics of DDR protein recruitment

    • Determine if H3K23ac precedes or follows other DDR events

    • Use live-cell imaging with modification-specific intrabodies when possible

  • Functional manipulation approaches:

    • Inhibit HATs or HDACs that target H3K23

    • Use CRISPR-based epigenome editing to alter H3K23ac at specific loci

    • Generate H3K23 mutants (K23R or K23Q) to assess functional impact

    • Target H3K23ac readers for depletion or inhibition

  • Specialized analytical considerations:

    • Account for chromatin changes induced by damage when analyzing ChIP-seq data

    • Implement normalization strategies that compensate for global histone loss at damage sites

    • Develop methodologies to identify damage-specific peaks versus normal H3K23ac distribution

    • Correlate H3K23ac changes with repair efficiency measurements

This comprehensive methodological approach enables researchers to establish causal relationships between H3K23 acetylation and DNA damage response pathways while accounting for the complex nature of chromatin dynamics during DNA repair.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.